Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Impairment of active avoidance by the noradrenergic neurotoxin, DSP4: attenuation by post-training epinephrine

  • 33 Accesses

  • 17 Citations

Abstract

Male Sprague-Dawley rats were treated with the selective noradrenergic neurotoxin, DSP4 prior to behavioral assessment. They were trained in an inhibitory avoidance and a one-way active avoidance task and given post-training treatment with epinephrine (EPI, 0.1 mg/kg, SC) or physiological saline. Performance on these tests was assessed at time points after treatment with DSP4 when (1) both central NE and sympathetic catecholamines were depleted and when (2) sympathetic catecholamines had returned to control levels and central NE remained depleted. Activity was also assessed at two time points after DSP4 treatment. DSP4 treatment had no effect upon inhibitory avoidance retention but impaired one-way active avoidance shuttle performance at both time points following DSP4 treatment. There was a transient depression of spontaneous activity which may indicate a deficit of behavioral initiation during the early phase after DSP4 treatment when the sympathetic catecholamine levels were depleted. This finding suggests that the peripheral sympathetic system may support some aspect of behavioral initiation. Epinephrine (0.1 mg/kg SC) administered after active avoidance training ameliorated the active avoidance retention performance deficit seen 4 days after DSP4 treatment. Post-training EPI did not significantly affect active avoidance retention performance when animals were trained and tested after peripheral sympathetic recovery (approximately 2 weeks after DSP4 treatment). These findings suggest that peripheral adrenergic activation plays a role in the EPI facilitation of retention performance in this task. As the facilitatory effects of peripherally circulating epinephrine were expressed in the presence of a severely depleted dorsal noradrenergic bundle system, they do not appear to depend upon the stimulation of NE released from this system. The present data, however, do not exclude the possibility that the modulation by peripheral EPI may depend upon its stimulation of NE release at other loci of central noradrenergic innervation.

This is a preview of subscription content, log in to check access.

References

  1. Archer T (1982) DSP4 (N-2-chloroethyl-N-ethyl-2-bromobenzylamine) a new noradrenaline neurotoxin, and stimulus conditions affecting acquisition of two-way active avoidance. J Comp Physiol 63:117–120

  2. Archer T, Ogren SO, Johansson G, Ross SB (1982) DSP4-induced two-way active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion. Psychopharmacology 76:303–309

  3. Bennett C, McGaugh JL, Arnold M, Liang KC (1983) Behavioral measures after central noradrenergic depletion with the neurotoxin, DSP-4: lack of impairment in avoidance tasks. Neurosci Abstr 9:831

  4. Bennett C, Hock F, McGaugh JL (1984) Dose and time dependence of noradrenergic depletion after N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4). IRCS Med Sci 12:181–182

  5. Bennett C, Kaleta S, McGaugh JL (1985a) Dose and time response characteristics of whole brain monoamines to yohimbine after central norepinephrine depletion with DSP4. IRCS Med Sci 13:36–37

  6. Bennett C, Liang KC, McGaugh JL (1985b) Depletion of adrenal catecholamines alters the amnestic effect of amygdala stimulation. Behav Brain Res 15:83–91

  7. Bennett MC (1984) Some behavioral effects of the selective neurotoxin, N-(2-chlorethyl)-N-ethyl-2-bromobenzylamine (DSP4). Doctoral Dissertation

  8. de Almeida M, Kapczinski FP, Izquierdo I (1983) Memory modulation by posttraining intraperitoneal but not intracerebroventricular administration of ACTH or epinephrine. Behav Neural Biol 39:277–283

  9. Ellis ME, Kesner RP (1983) The noradrenergic system of the amygdala and aversive memory processing. Behav Neurosci 97:399–415

  10. Glowinski J, Iverson LL (1966) Regional studies of catecholamines in the rat brain. I. The disposition of (3H) norepinephrine, (3H) dopamine and (3H) dopa in various regions of the brain. J Neurochem 13:655–669

  11. Gold PE, van Buskirk RB (1975) Facilitation of time-dependent memory processes with posttrial epinephrine injections. Behav Biol 13:145–153

  12. Gold PE, van Buskirk R (1978) Post-training brain norepinephrine concentrations: correlations with retention performance of avoidance training and with peripheral epinephrine modulation of memory processing. Behav Biol 23:509–520

  13. Hallman H, Jonsson G (1980) DSP4 (N-2-chlorethyl-N-ethyl-12-bromobenzylamine) — a useful noradrenaline denervation tool in adult and developing rats. Neurosci Lett Suppl 5:365

  14. Ishikawa K, McGaugh JL (1982) Simultaneous determination of monoamine transmitters, precursors and metabolites in a single mouse brain. J Chromatogr 229:35–46

  15. Jaim-Etcheverry G, Zieher LM (1980) DSP-4: a novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats. Brain Res 188:513–523

  16. Jonsson G (1980) Chemical neurotoxins as denervation tools in neurobiology. Annu Rev Neurosci 3:169–187

  17. Jonsson G, Hallman H, Ponzio F, Ross S (1981) DSP4 (N-(2-chlorethyl)-N-ethyl-2-bromobenzylamine) — a useful denervation tool for central and peripheral noradrenaline neurons. Eur J Pharmacol 72:173–188

  18. Krueger CA, Cook DA (1975) Synthesis and adrenergic neuron blocking properties of some alkylating analogues of bretylium. Arch Int Pharmocodyn 218:96–105

  19. Liang KC, McGaugh JL (1983) Lesions of the stria terminalis attenuate the enhancing effect of post-training epinephrine on retention of an inhibitory avoidance response. Behav Brain Res 9:49–58

  20. Liang KC, Bennett C, McGaugh JL (1985) Peripheral epinephrine modulates the effects of posttraining amygdala stimulation on memory. Behav Brain Res 15:93–100

  21. Liang KC, Juler RG, McGaugh JL (1986) Modulating effects of posttraining epinephrine on memory involvement of the amygdala noradrenergic system. Brain Res 368:125–133

  22. Liang KC, McGaugh JL, Yao H-Y (1990) Involvement of amygdala pathways in the influence of posttraining amygdala norepinephrine and peripheral epinephrine on memory storage. Brain Res (in press)

  23. McGaugh JL (1983) Hormonal influences on memory. Ann Rev Psychol 34:297–323

  24. McGaugh JL, Introini-Collison IB, Nagahara AH (1988) Memory-enhancing effects of posttraining naloxone: involvement of β-noradrenergic influences in the amygdaloid complex. Brain Res 446:37–49

  25. Messing RB, Jensen RA, Martinez Jr, JL, Spiehler VR, Vasquez BJ, Soumireu-Mourat B, Liang KC, McGaugh JL (1979) Naloxone enhancement of memory. Behav Neural Biol 27:266–275

  26. Ross SB (1976) Long-term effects of N-2-chloroethyl-N-ethyl-2-bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart. Br J Pharmacol 58:521

  27. Ross SB, Renyi AL (1976) On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on the active uptake of noradrenaline. J Pharm Pharmacol 28:458

  28. Ross SB, Johansson JG, Lindbor B, Dahlbom R (1973) Tertiary N-(2-chloroethyl)-N-haloalkylamines with adrenergic blocking action. Acta Pharm Suec 10:29–42

  29. Weil-Malherbe H, Axelrod J, Tomchick R (1959) Blood-brain barrier for adrenaline. Science 129:1226–1228

Download references

Author information

Correspondence to James L. McGaugh.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bennett, M.C., Kaleta-Michaels, S., Arnold, M. et al. Impairment of active avoidance by the noradrenergic neurotoxin, DSP4: attenuation by post-training epinephrine. Psychopharmacology 101, 505–510 (1990). https://doi.org/10.1007/BF02244229

Download citation

Key words

  • DSP4
  • Dorsal noradrenergic bundle (DNB)
  • Norepinephrine
  • Epinephrine
  • Learning
  • Memory rats
  • Active avoidance